Active	Status	Sponsor type	Region	Phase	Filter
10 Active 5 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wu, Jennifer M
SRF388-201, NCT05359861: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma	Active, not recruiting	2	134	US, RoW	SRF388, Atezolizumab, Tecentriq, Bevacizumab, Avastin, Placebo	Coherus Biosciences, Inc.	Hepatocellular Carcinoma	05/25	05/26
NCT03496051: Single Patient Access (Compassionate Use) for Continued Treatment of RO7070179 for Adult Subjects With Advanced Hepatocellular Carcinoma (HCC)	Available	N/A		US	RO7070179	New York University School of Medicine, Roche-Genentech	Hepatocellular Carcinoma
Margulies, Samantha L
No trials found
Kunycky, Christina
No trials found